From October 1, 2022 to December 30, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 3,909,896 shares, representing 0.45% for CNY 369.4 million under the buyback announced on February 13, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
53.01 CNY | +0.78% | +2.47% | -3.57% |
Apr. 25 | Hangzhou Tigermed Consulting’s Profit Down 59% in Q1 | MT |
Apr. 25 | Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.57% | 5.92B | |
+2.00% | 42.59B | |
+7.12% | 40.65B | |
+49.11% | 40.57B | |
-11.96% | 26.77B | |
+8.60% | 24.81B | |
-23.92% | 18.17B | |
+27.04% | 12.05B | |
-3.15% | 11.7B | |
+7.18% | 11.1B |
- Stock Market
- Equities
- 300347 Stock
- News Hangzhou Tigermed Consulting Co., Ltd
- Tranche Update on Hangzhou Tigermed Consulting Co., Ltd.'s Equity Buyback Plan announced on February 13, 2022.